文献速递肿瘤 PET/CT放射性药物与辐射防护

从鸵鸟到小鼠到人:[68Ga]Ga-TEoS-DAZA功能性肝脏PET示踪剂的转化研究

From Ostrich to Mouse to Human: Translation of the Functional Liver PET Tracer [68Ga]Ga-TEoS-DAZA.
PubMed 文献 · J Nucl Med · 2026-04-01

本研究在鸵鸟胚胎、健康小鼠和健康人类肝脏供体中探究了[68Ga]Ga-TEoS-DAZA的动态生物分布,并研究了其分子通路和代谢。结果显示该示踪剂在三种物种中均显示肝脏特异性摄取和胆道排泄,但在小鼠中肝脏转运时间显著快于鸵鸟胚胎和人类。该示踪剂是OATP1B3的底物,且存在肝代谢产物。

要点

  • 三种物种中[68Ga]Ga-TEoS-DAZA均显示肝脏特异性摄取(峰值30-40 %IA)和胆道排泄,肾脏排泄少于5 %IA。
  • 小鼠肝脏转运时间显著快于鸵鸟胚胎和人类,小鼠达峰时间1.7 min,其他两种物种为15-21 min。
  • 该示踪剂是OATP1B3底物,环孢素A可阻碍其肝脏摄取,且组织样本中发现未知的放射性代谢物。

核心结论

  • [68Ga]Ga-TEoS-DAZA在鸵鸟胚胎和小鼠中均显示为合适的肝胆示踪剂,但两种临床前模型在肝脏摄取和胆道排泄速度上与人类存在差异,限制了转化性。

研究设计与样本

  • 本研究在2种临床前模型(鸵鸟胚胎和健康小鼠C57BL/6)和1名健康人类肝脏供体中进行[68Ga]Ga-TEoS-DAZA的动态生物分布PET/CT研究。
  • 在转染的HEK293t细胞中进行肝细胞转运体结合研究,在鸵鸟胚胎和健康肝脏供体样本中进行代谢分析,并在鸵鸟胚胎中进行环孢素A阻断研究。

主要发现

  • [68Ga]Ga-TEoS-DAZA在鸵鸟胚胎、健康小鼠和健康供体中的生物分布具有可比性,三种物种中均显示肝脏组织特异性摄取(峰值时30-40 %IA)和后续胆道排泄,肾脏排泄少于5 %IA。
  • 小鼠肝脏转运时间显著快于鸵鸟胚胎和人类,小鼠达峰时间(1.7 min)远短于其他两种物种(15-21 min),且示踪剂从肝脏快速清除至肠道。
  • [68Ga]Ga-TEoS-DAZA是OATP1B3的底物,环孢素A存在时肝脏摄取受阻。
  • 组织样本中发现了[68Ga]Ga-TEoS-DAZA的一种未知放射性代谢物,提示存在肝脏代谢。

关键数值与推荐

  • 三种物种中肝脏摄取峰值均为30-40 %IA,肾脏排泄均少于5 %IA。
  • 小鼠达峰时间为1.7 min,鸵鸟胚胎和人类为15-21 min。

临床怎么用

  • 该示踪剂可用于肝胆功能PET显像,但临床前模型(小鼠和鸵鸟胚胎)在肝脏摄取和胆道排泄速度上与人类存在差异,需谨慎解读临床前数据向人类的转化。
  • OATP1B3底物特性提示需关注药物相互作用(如环孢素A)对肝脏摄取的影响。

局限性

  • 小鼠和鸵鸟胚胎模型在肝脏摄取和胆道排泄速度上与人类存在明显差异,限制了两种模型的转化性。
  • 研究样本量有限(1名健康人类供体),未报告统计学比较或P值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of this study was to investigate the dynamic biodistribution of [68Ga]Ga-TEoS-DAZA, a functional liver PET tracer, in 2 preclinical models (ostrich embryos and mice) and in a healthy human liver donor to identify similarities and differences among the 3 species, which are relevant in translational nuclear medicine. Furthermore, the molecular pathway and metabolism of [68Ga]Ga-TEoS-DAZA was investigated. Methods: The dynamic biodistribution of [68Ga]Ga-TEoS-DAZA was determined via PET/CT in ostrich embryos, in healthy mice (C57BL/6), and in a healthy human liver donor. Hepatocyte transporter binding studies were performed in transfected HEK293t cells. Metabolite analysis was performed in samples from ostrich embryos and a healthy liver donor. Blocking studies against cyclosporine A were performed in ostrich embryos. Results: The biodistribution of [68Ga]Ga-TEoS-DAZA was comparable in ostrich embryos, healthy mice (C57BL/6), and the healthy donor. In all 3 species, the tracer showed specific uptake in liver tissue (30-40 %IA at time of peak) and subsequent biliary excretion, whereas less than 5 %IA activity was excreted renally. The hepatic transit time in mice was significantly faster than in ostrich embryos and human, with mice exhibiting a much shorter time-to-peak (1.7 min) than the other 2 species (15-21 min) and rapid clearance of the tracer from the liver into the intestines. [68Ga]Ga-TEoS-DAZA is a substrate for OATP1B3, with tracer uptake into the liver being hampered in the presence of cyclosporine A. Tissue samples revealed an as yet unknown radiometabolite of [68Ga]Ga-TEoS-DAZA, indicating hepatic metabolism. Conclusion: [68Ga]Ga-TEoS-DAZA was shown to be a suitable hepatobiliary tracer using both mice and ostrich embryos as preclinical models; however, there were limits in translatability in both models because of a distinctly faster hepatic uptake and biliary excretion (mice) or a slower biliary excretion (ostrich embryo) compared with that in the human.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Greiser J, Drescher R, Sonawane M, et al. From Ostrich to Mouse to Human: Translation of the Functional Liver PET Tracer [68Ga]Ga-TEoS-DAZA. J Nucl Med. 2026. PMID: 42437749. doi:10.2967/jnumed.125.271020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。